These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 21244657)

  • 1. Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review.
    Atsou K; Chouaid C; Hejblum G
    BMC Med; 2011 Jan; 9():7. PubMed ID: 21244657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one other long-term condition: a mixed methods review.
    Dennett EJ; Janjua S; Stovold E; Harrison SL; McDonnell MJ; Holland AE
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013384. PubMed ID: 34309831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost of disorders of the brain in Europe 2010.
    Gustavsson A; Svensson M; Jacobi F; Allgulander C; Alonso J; Beghi E; Dodel R; Ekman M; Faravelli C; Fratiglioni L; Gannon B; Jones DH; Jennum P; Jordanova A; Jönsson L; Karampampa K; Knapp M; Kobelt G; Kurth T; Lieb R; Linde M; Ljungcrantz C; Maercker A; Melin B; Moscarelli M; Musayev A; Norwood F; Preisig M; Pugliatti M; Rehm J; Salvador-Carulla L; Schlehofer B; Simon R; Steinhausen HC; Stovner LJ; Vallat JM; Van den Bergh P; van Os J; Vos P; Xu W; Wittchen HU; Jönsson B; Olesen J;
    Eur Neuropsychopharmacol; 2011 Oct; 21(10):718-79. PubMed ID: 21924589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM
    Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G
    Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychological therapies for the treatment of depression in chronic obstructive pulmonary disease.
    Pollok J; van Agteren JE; Esterman AJ; Carson-Chahhoud KV
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012347. PubMed ID: 30838649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuing to Confront COPD International Patient Survey: methods, COPD prevalence, and disease burden in 2012-2013.
    Landis SH; Muellerova H; Mannino DM; Menezes AM; Han MK; van der Molen T; Ichinose M; Aisanov Z; Oh YM; Davis KJ
    Int J Chron Obstruct Pulmon Dis; 2014; 9():597-611. PubMed ID: 24944511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations for COPD management in Central and Eastern Europe.
    Valipour A; Aisanov Z; Avdeev S; Koblizek V; Kocan I; Kopitovic I; Lupkovics G; Man M; Bukovskis M; Tudoric N; Vukoja M; Naumnik W; Yanev N
    Expert Rev Respir Med; 2022 Feb; 16(2):221-234. PubMed ID: 35001780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and health economics of COPD across Europe: a critical analysis.
    Nowak D; Berger K; Lippert B; Kilgert K; Caeser M; Sandtmann R
    Treat Respir Med; 2005; 4(6):381-95. PubMed ID: 16336024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in prevalence, mortality, and disability-adjusted life-years relating to chronic obstructive pulmonary disease in Europe: an observational study of the global burden of disease database, 2001-2019.
    Marshall DC; Al Omari O; Goodall R; Shalhoub J; Adcock IM; Chung KF; Salciccioli JD
    BMC Pulm Med; 2022 Jul; 22(1):289. PubMed ID: 35902833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of chronic obstructive pulmonary disease: a literature review.
    Rycroft CE; Heyes A; Lanza L; Becker K
    Int J Chron Obstruct Pulmon Dis; 2012; 7():457-94. PubMed ID: 22927753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supported self-management for patients with moderate to severe chronic obstructive pulmonary disease (COPD): an evidence synthesis and economic analysis.
    Jordan RE; Majothi S; Heneghan NR; Blissett DB; Riley RD; Sitch AJ; Price MJ; Bates EJ; Turner AM; Bayliss S; Moore D; Singh S; Adab P; Fitzmaurice DA; Jowett S; Jolly K
    Health Technol Assess; 2015 May; 19(36):1-516. PubMed ID: 25980984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease.
    Lenferink A; Brusse-Keizer M; van der Valk PD; Frith PA; Zwerink M; Monninkhof EM; van der Palen J; Effing TW
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011682. PubMed ID: 28777450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis.
    Adeloye D; Song P; Zhu Y; Campbell H; Sheikh A; Rudan I;
    Lancet Respir Med; 2022 May; 10(5):447-458. PubMed ID: 35279265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [COPD: Burden, risk factors and prevalence].
    Karpinski NA; Petermann F
    Gesundheitswesen; 2009 Dec; 71(12):816-22. PubMed ID: 19621281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Worldwide burden of COPD in high- and low-income countries. Part I. The burden of obstructive lung disease (BOLD) initiative.
    Buist AS; Vollmer WM; McBurnie MA
    Int J Tuberc Lung Dis; 2008 Jul; 12(7):703-8. PubMed ID: 18544191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study.
    Buist AS; McBurnie MA; Vollmer WM; Gillespie S; Burney P; Mannino DM; Menezes AM; Sullivan SD; Lee TA; Weiss KB; Jensen RL; Marks GB; Gulsvik A; Nizankowska-Mogilnicka E;
    Lancet; 2007 Sep; 370(9589):741-50. PubMed ID: 17765523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The epidemiology and burden of COPD in Latin America and the Caribbean: systematic review and meta-analysis.
    Ciapponi A; Alison L; Agustina M; Demián G; Silvana C; Edgardo S
    COPD; 2014 Jun; 11(3):339-50. PubMed ID: 24111903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease.
    Maqsood U; Ho TN; Palmer K; Eccles FJ; Munavvar M; Wang R; Crossingham I; Evans DJ
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012930. PubMed ID: 30839102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.